(1 - 8 from 9
)
Improved Outcomes in Certain Lymphomas With Ibritumomab Tiuxetan...
www.rxpgnews.com
Oliver Weigert, M.D., University Hospital Grosshadern/LMU, Munich, Germany, presented data from two Phase 2 trials of patients with relapsed ...
sorted by relevance / date